|Bid||5.25 x 1100|
|Ask||5.30 x 800|
|Day's Range||5.20 - 5.30|
|52 Week Range||2.15 - 6.63|
|PE Ratio (TTM)||-3.75|
|Earnings Date||May 4, 2017 - May 8, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||7.90|
Categories: Yahoo FinanceGet free summary analysis CombiMatrix Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of CombiMatrix Corp. – Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, NeoGenomics, Inc., RadNet, Inc. and Transgenomic, Inc. (DGX-US, LH-US, NEO-US, RDNT-US and TBIO-US) that have also reported for ... Read more (Read more...)
IRVINE, Calif., May 22, 2017-- CombiMatrix Corporation, a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing services, announces that management ...
NEW YORK, NY / ACCESSWIRE / May 8, 2017 / Positive economic data and continued strength in corporate earnings pushed U.S. markets into the green Friday. The Dow Jones Industrial Average gained 0.26 percent ...